Diaphragmatic dysfunction in neuromuscular disease, an MRI study

[1]  Gijs van Tulder,et al.  Chest MRI to diagnose early diaphragmatic weakness in Pompe disease , 2021, Orphanet Journal of Rare Diseases.

[2]  Simona Matteini,et al.  Evaluation of diaphragm thickening by diaphragm ultrasonography: a reproducibility and a repeatability study , 2020, Journal of Ultrasound.

[3]  A. Aliverti,et al.  Diaphragm Involvement in Duchenne Muscular Dystrophy (DMD): An MRI Study , 2020, Journal of magnetic resonance imaging : JMRI.

[4]  E. De Mattia,et al.  The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients , 2019, Clinical Neurology and Neurosurgery.

[5]  W. Triplett,et al.  Imaging respiratory muscle quality and function in Duchenne muscular dystrophy , 2019, Journal of Neurology.

[6]  T. Bocci,et al.  Diaphragm ultrasonography in amyotrophic lateral sclerosis: a diagnostic tool to assess ventilatory dysfunction and disease severity , 2019, Neurological Sciences.

[7]  A. Aliverti,et al.  Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients , 2018, PloS one.

[8]  Francesco Muntoni,et al.  Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction , 2018, Nature Reviews Neurology.

[9]  P. Matthews,et al.  Semi-Automated Analysis of Diaphragmatic Motion with Dynamic Magnetic Resonance Imaging in Healthy Controls and Non-Ambulant Subjects with Duchenne Muscular Dystrophy , 2018, Front. Neurol..

[10]  Marleen de Bruijne,et al.  Imaging of respiratory muscles in neuromuscular disease: A review , 2017, Neuromuscular Disorders.

[11]  S. Wenninger,et al.  Respiratory involvement in neuromuscular disorders , 2017, Current opinion in neurology.

[12]  M. de Carvalho,et al.  Comparison of slow and forced vital capacities on ability to predict survival in ALS , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[13]  A. Boon,et al.  Utility Of diaphragm ultrasound in myopathy , 2017, Muscle & nerve.

[14]  Marleen de Bruijne,et al.  Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI , 2016, PloS one.

[15]  M. Swash,et al.  Ultrasound for assessment of diaphragm in ALS , 2016, Clinical Neurophysiology.

[16]  Stefania Mondello,et al.  Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment , 2015, Neuromuscular Disorders.

[17]  Michael A. Grippi editor-in-chief.  Fishman’s pulmonary diseases and disorders , 2015 .

[18]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[19]  Marleen de Bruijne,et al.  Lung MRI and impairment of diaphragmatic function in Pompe disease , 2015, BMC Pulmonary Medicine.

[20]  M. Swash,et al.  The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  F. Mastaglia,et al.  Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis , 2014, Neuromuscular Disorders.

[22]  O. Pansarasa,et al.  Amyotrophic Lateral Sclerosis and Skeletal Muscle: An Update , 2014, Molecular Neurobiology.

[23]  N. Romero,et al.  Congenital myopathies. , 2013, Handbook of clinical neurology.

[24]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[25]  W. Hop,et al.  Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease. , 2011, Molecular genetics and metabolism.

[26]  D. Selcen.  Myofibrillar myopathies , 2011, Neuromuscular Disorders.

[27]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[28]  M. Tarnopolsky,et al.  Metabolic Myopathies: Update 2009 , 2009, Journal of clinical neuromuscular disease.

[29]  J. D. Kennedy,et al.  Chronic respiratory failure and neuromuscular disease. , 2009, Pediatric clinics of North America.

[30]  P. Halpern,et al.  Mechanics of respiratory muscles , 2008, Respiratory Physiology & Neurobiology.

[31]  A. Pestronk,et al.  Frequent atrophic groups with mixed‐type myofibers is distinctive to motor neuron syndromes , 2007, Muscle & nerve.

[32]  M. Zwarts,et al.  Primary respiratory failure in inclusion body myositis , 2004, Neurology.

[33]  W. Frontera,et al.  Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis , 2002, Muscle & nerve.

[34]  J. Gilchrist.  Overview of Neuromuscular Disorders Affecting Respiratory Function , 2002, Seminars in respiratory and critical care medicine.

[35]  A. Beggs,et al.  Nemaline myopathy: A clinical study of 143 cases , 2001, Annals of neurology.

[36]  A. Beggs,et al.  Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filaments. , 2001, Trends in molecular medicine.

[37]  D. Dantzker,et al.  Inclusion body myositis as a cause of respiratory failure. , 1993, Chest.

[38]  J Moxham,et al.  The respiratory muscles. , 1988, Praxis und Klinik der Pneumologie.

[39]  S. H. Wilson,et al.  Predicted normal values for maximal respiratory pressures in caucasian adults and children. , 1984, Thorax.

[40]  Sotirios A. Tsaftaris,et al.  Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015 , 2015, Lecture Notes in Computer Science.

[41]  Gary C. Sieck,et al.  ATS/ERS Statement on respiratory muscle testing. , 2002, American journal of respiratory and critical care medicine.

[42]  D. Annane,et al.  Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. , 2001, Archives of physical medicine and rehabilitation.